Clinical Trial Update: Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics, and cardiac function after repeat dosing of SB-649868 in healthy volunteers has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Disorders

Drugs mentioned

• SB-649868

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sleep Disorders | Phase 1 | Status: COMPLETED